Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents
Vikram Jeet Singh, Bharti Sharma, Pooja A. Chawla
Bioorganic Chemistry (2021) Vol. 114, pp. 105161-105161
Closed Access | Times Cited: 15

Showing 15 citing articles:

Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview
Eunüs S. Ali, Shamima Akter, Sarker Ramproshad, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors
Islam H. Ali, Heba T. Abdel‐Mohsen, Marwa M. Mounier, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105883-105883
Closed Access | Times Cited: 30
MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway
Guo-Rung You, Joseph T. Chang, Yan-Liang Li, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2855-2855
Open Access | Times Cited: 23
The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells
Min Zhou, Joelle C. Boulos, Sabine M. Klauck, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2971-2997
Open Access | Times Cited: 13
Quercetin modulates signal transductions and targets non-coding RNAs against cancer development
Mina Homayoonfal, Hamidreza Gilasi, Zatollah Asemi, et al.
Cellular Signalling (2023) Vol. 107, pp. 110667-110667
Closed Access | Times Cited: 11
Design, synthesis, molecular dynamics simulation, MM/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids
Shriram D. Ranade, Shankar G. Alegaon, Venkatasubramanian Ulaganathan, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107881-107881
Closed Access | Times Cited: 10
Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity
Seyed–Omar Zaraei, Nour N. Alach, Hanan S. Anbar, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114434-114434
Open Access | Times Cited: 16
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer
Hasan Alsharoh, Paul Chiroi, Ekaterina Isachesku, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1489-1489
Open Access | Times Cited: 2
1,5-Benzothiazepine Derivatives: Green Synthesis, In Silico and In Vitro Evaluation as Anticancer Agents
Michelyne Haroun, Santosh S. Chobe, Rajasekhar Reddy Alavala, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3757-3757
Open Access | Times Cited: 13
Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
Anna Salvati, Klaas Poelstra
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 217-217
Open Access | Times Cited: 9
The mystery of titan hunter: Rationalized striking of the MAPK pathway via Newly synthesized 6‐Indolylpyridone‐3‐Carbonitrile derivatives
Mohamed M. Saleh, Tarek F. El‐Moselhy, Eman A. El-Bastawissy, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115675-115675
Closed Access | Times Cited: 2
In vitro and in silico cytotoxicity effects of Zanthoxylum simulans Hance. fruit bark extract against gastric cancer cell lines
Bùi Thanh Tùng, Nguyễn Thị Thủy, Lê Thi Huong, et al.
Journal of Research in Pharmacy (2024) Vol. 28(1), Iss. 28(1), pp. 110-125
Open Access
A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases
Nilam Bhusare, MAUSHMI KUMAR
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 849-875
Open Access
Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors
Bing Yang, Bo Zhang, Qun Zhao, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2404-2404
Open Access | Times Cited: 1
Medicinal Attributes of Heterocyclic Compounds in Rheumatoid Arthritis: Recent Developments and SAR Studies
Vikram Jeet Singh, Bharti Sharma, Pooja A. Chawla
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 22, pp. 1821-1846
Closed Access
Page 1

Scroll to top